Hjem › Seglcelle-anæmi › Indiana
Seglcelle-anæmi kliniske forsøg i Indiana
5 studier for Seglcelle-anæmi søger deltagere på steder i Indiana.
Byer i Indiana
Officiel studietekst (engelsk)
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
- Indiana Hemophilia & Thrombosis Center, Indianapolis
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07656415A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Innovative Hematology - Indiana Hemophilia & Thrombosis Center, Indianapolis
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07187973ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Indiana Hemophilia and Thrombosis Center, Indianapolis
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. aug. 2026 · NCT04398628The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Indiana University Health Riley Hospital for Children- Site Number : 8400056, Indianapolis
RekruttererFase 3
Alder 10 til 65 · Alle køn · Opdateret 29. jul. 2026 · NCT06975865Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Riley Children's Hospital (MRD-HCT), Indianapolis
- Riley's Children Hospital (NT-DMT), Indianapolis
RekruttererObservationsstudie
Alder 3 til 20 · Alle køn · Opdateret 4. jun. 2026 · NCT06941389Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.